Search results
Earnings call: GSK forecasts growth with strong Q1 performance By Investing.com
Investing.com· 13 hours agoGSK upgraded its full-year guidance, expecting another year of substantial growth for shareholders,...
Lawsuit Funding Leader Launches New Page for Pharmaceutical Bad Drug Lawsuits
CW39 NewsFix· 3 days agoPre-Settlement Funding Firm has specialized in funding for pharmaceutical drug lawsuits for over a decade, and has an experienced team to handle high-intake requests for those who've experienced ...
When judges get free trips to luxury resorts, disclosure is spotty
NPR· 4 days agoFederal judges — occasionally with family members or even their dog in tow — traveled to luxury...
Top Analyst Reports for AstraZeneca, QUALCOMM & FedEx
Zacks via Yahoo Finance· 1 day agoToday's Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC...
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
Zacks via Yahoo Finance· 4 days agoShares of this drugmaker have returned -10% over the past month versus the Zacks S&P 500 composite's...
Earnings call: GSK forecasts growth with strong Q1 performance By Investing.com
Investing.com· 13 hours agoGSK upgraded its full-year guidance, expecting another year of substantial growth for shareholders,...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition - KVIA
ABC 7 El Paso· 4 days agoBy MATTHEW PERRONE AP Health Writer WASHINGTON (AP) — The Federal Trade Commission is challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic. Tuesday ...
Marijuana Reclassification Puts Politics and Profits Ahead of Public Health
Newsweek· 2 days agoThe first major change to federal marijuana laws may be on the horizon now that it has been leaked...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Associated Press via Yahoo News· 4 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight
Guru Focus· 22 hours agoOn May 3, 2024, AbbVie Inc (ABBV, Financial), a global biopharmaceutical powerhouse, filed its 10-Q report, revealing a comprehensive snapshot of its financial health and strategic positioning ...
